John Freshley
Venture Partner

John Freshley is a Venture Partner at Orange Grove Bio and heads up the firm's operations in Michigan. John is an entrepreneur, company builder and leader having founded, launched and/or led 8 early stage biotech companies, including drug development companies in oncology and ophthalmology which he hopes to bring to the Orange Grove Bio portfolio.

He recently led ONL Therapeutics as its CEO from discovery through pre-clinical development, with lead product entering Phase 1 in Q4 2019.

Previously launched Compendia Bioscience as start-up CEO and remained as Chief Business Officer through its acquisition by Life Technologies (now Thermo Fisher).